Florida nurse practitioner convicted in $200 million Medicare fraud scheme

Florida nurse practitioner convicted in 0 million Medicare fraud scheme


Michael Nesterov | Istock | Getty Images

A federal jury in Miami convicted a Florida nurse practitioner of health-care conspiracy and other charges for playing a key role in a scheme that swindled hundreds of millions of dollars from Medicare.

Elizabeth Hernandez, 45, fraudulently billed Medicare for more than $200 million in orthotic braces and genetic tests that were medically unnecessary, according to the Department of Justice.

Medicare is the federal program that provides health coverage to primarily older Americans.

Hernandez, who was found guilty Thursday by jurors after a trial that lasted several days, participated in a broad scheme in which telemarketing companies would contact Medicare patients to persuade them to request unnecessary braces and tests, the DOJ said.

CNBC Politics

Read more of CNBC’s politics coverage:

These companies then sent pre-filled orders to Hernandez, who signed them, attesting that she had examined or treated the patients although she had never spoken with many of them, prosecutors said.

Hernandez routinely billed Medicare for more than 24 hours of purported “office visits” in a single day, the DOJ said.

And, “In 2020, Hernandez ordered more cancer genetic tests for Medicare beneficiaries than any other provider in the nation, including oncologists and geneticists,” the department said.

She personally pocketed $1.6 million in stolen money which she used to buy pricey cars, jewelry, home renovations and trips, the prosecutors said.

Hernandez is scheduled to be sentenced Dec. 14. She faces a maximum possible sentence of 20 years in prison on the top count of conspiracy to commit health care fraud, with lesser maximums for health care fraud and making false statements.

A lawyer for Hernandez did not immediately respond to a request for comment.



Source

JPMorgan’s top biotech and pharma picks for the second half
Health

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]

Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More